# Page 1
Haffkine Biopharmaceuticals Manufacturing Corporation (M.I. ), Government approval and financing of the change in various aspects of the project in line with the action taken to implement the project to produce Covaxin vaccine in collaboration with the Central and State Governments in Mumbai.
The Government of Maharashtra
Department of Medical Education and Drugs
Government Resolution No: HBP-2021/ PR No.53/ Drugs-1
Hospital, 9th floor,
Tilak Marg, Mantralaya, Mumbai 400 001
The date is April 11, 2022.
Department of Medical Education and Pharmaceuticals, Government Resolution No. HBP-2021/ PR No. 53/ Drugs-1,
dated 29.04.2021.
Department of Medical Education and Pharmaceuticals, Government Decision No. HBP-2021/ Q. No. 62/21/ Drugs-1,
dated 04.06.2021.
3) Managing Director, Haffkine Biopharmaceutical Corporation, Mumbai vide letter No. HBPCL/
Term Sheet/ 2021/233, dated 08.12.2021.
4) Letter from the Managing Director, Haffkine Biopharmaceuticals Corporation, Mumbai.
2022/20, dated 22.02.2022.
Preamble: Central and State Governments at the site of Haffkine Pharmaceuticals Limited, Parel, Mumbai
Funding and May Bharat Biotech International Limited, Hyderabad on COVID-19 pandemic
Proposal to produce this vaccine using the technology of Covaxin vaccine
Reference No. 1 Government approval has been accorded vide Government Resolution dated 29.04.2021. The project
The cost of the project is Rs. 154.00 crore. Sadar
The Central Government has allotted Rs. A sum of Rs. 65.00 crore has been sanctioned. The project cost of Rs.
154.00 crore out of the remaining capital (non-recurring) expenditure of Rs. Haffkine Financial Assistance of Rs. 94.1665 Crore
# Page 2
Government Resolution, Department of Medical Education and Pharmaceuticals No: HBP-2021/ Q. No. 53/21/ Drugs-1
The corporation has been sanctioned as seed capital. Managing Director, Haffkine Biopharma
The Construction Corporation (MIRIA), Mumbai has issued the above mentioned No. 4 As per letter dated 22.02.2022
The Government has been requested to take the lead from M/ s Bharat Biotech in implementing the project at the initial stage
Changes in the production technology received by the corporation and the installed capacity produced (Installed
Dedicated required facility compatible with the production technology of M/ s Bharat Biotech
BSL-3 Laboratory Upgradation of Establishment, Haffkine Training, Research and Testing Institute, Taxation and other matters
Including the increase in the original sanctioned amount of the project, in the original budget of the project
All of the improvements. To be brought to the notice of the Cabinet and the changes made accordingly
Cabinet approval is required. Accordingly, the proposal has been made. the Cabinet
The recommendations were presented in the meeting held on 31.03.2022. At the meeting
The cabinet has approved the proposal of Haffkine Corporation. Accordingly, the government
The following decision has been taken:
Government's decision:
Department of Medical Education and Pharmaceuticals, with the approved items mentioned in the Government Decision dated 29.04.2021
Government approval is being accorded in respect of the following new items:
1) Haffkine Biopharmaceuticals Manufacturing Corporation (MIRIA. Mumbai, in collaboration with the Central and State Governments.
Revised Project Report and Scope of Covaxin Vaccine Project to be implemented
It's approved.
110 million doses using cell factory-based production technology in the first phase of the project
The production of the same Covaxin Drug Substance is being approved.
3) In the first phase, Covaxin Drug Substance of Rs. 126.15 crore (including taxes).
Revised Budget (as per Form-A) being approved (Central share 70.07)
Page 2 of 6
# Page 3
Government Resolution, Department of Medical Education and Pharmaceuticals No: HBP-2021/ Q. No. 53/21/ Drugs-1
crore and the State Government Rs. 56.08 crore). As well as the cost of the project
It is being approved from the budgeted funds.
4) For the first phase of Covaxin Drug Substance, Rs. 126.15 crore (including taxes).
Haffkine Institute of Training, Research and Testing, Mumbai from the revised budget amount.
BSL- 2/3 Laboratories under their jurisdiction for upgradation, training and
Increase in testing capacity etc. Rs. 10.19 crore sanctioned
is being provided.
As per the Action Plan of Biotechnology Industry Research Assistance Council (BIRAC) in the first phase
M/ s Bharat to supply Covaxin Drug Substance to be manufactured by the Corporation
BBIL's marketing authorization
Haffkine to sell Covaxin drug product and take further action
The company is approved.
6) First batch of Covaxin for Drug Substance received from M/ s Bharat Biotech
Approval is being given to finalize the Term Sheet at Annexure-A along with the Cabinet Note
is.
7) Haffkine Biopharmaceuticals Manufacturing Corporation (MIRIA. ), Mumbai through COVID-19 preventive Covaxin
The government has taken the decision to speed up the construction of vaccine production plant. H.P.- 2021
62/21/ Drugs-1 dated 04.06.2021. Chief Secretary, Maharashtra
A high-level committee has been constituted to oversee the project.
It's approved.
(2) The decision shall be taken by the Finance Department, the Planning Department and the Law and Justice Department respectively.
Informal reference no. 138/2022/ Expenditure-13, dated 02.03.2022, Informal Reference No. 108/1475,
Page 3 of 6
# Page 4
Government Resolution, Department of Medical Education and Pharmaceuticals No: HBP-2021/ Q. No. 53/21/ Drugs-1
dated 28.02.2022, Informal Reference No. 144-2022/ E, dated 03.03.2022
Approval is being given.
# Page 5
# Page 6